ERBB2 and breast carcinoma: In a cell culture experiment, the suppression of breast cancer cell growth, increased apoptosis and senescence molecular markers (p53, p21, p16, and p27), and a decreased expression of ErbB2 was observed in the cells treated with annatto-T3.